Pharmacologic Advancement in Schizophrenia

dc.contributor.author	Hafiza Tuseef Sayyar
dc.contributor.author	Afshan Siddiq
dc.date.accessioned	2020-07-24T08:31:58Z
dc.date.available	2020-07-24T08:31:58Z
dc.date.issued	2020-07-01
dc.identifier.issn	2220-7562
dc.identifier.uri	http://hdl.handle.net/123456789/9339
dc.description.abstract	Schizophrenia is a disorder of mental debility characterized by abnormal social behavior in which person is unable to recognize reality. The sign and symptoms are variable and heterogeneous. Due to the diverse symptoms and variable treatment response, it is challenging to treat. Recent advancements in genomic, epidemiology and neurosciences can provide the appropriate medicines and treatments for minimizing symptoms and consequences of schizophrenia. This literature review was highlights the etiology, pathophysiology, neurotransmitter system, novel treatment and management of schizophrenia.The mainstay treatment of schizophrenic patients included antipsychotic drug with psychotherapy, social rehabilitation and job training	en_US
dc.description.sponsorship	JBUMDC	en_US
dc.language.iso	en	en_US
dc.publisher	Bahria University Medical and Dental College Karachi	en_US
dc.relation.ispartofseries	10;03
dc.subject	Antipsychotic drug, Schizophrenia, Pathophysiology, Neurotransmitter system	en_US
dc.title	Pharmacologic Advancement in Schizophrenia	en_US
dc.type	Article	en_US